Galmed Pharmaceuticals Ltd. - stock earnings
GLMD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -1.5 million USD | ? USD |
| 2023Q2 | -1.6 million USD | ? USD |
| 2023Q1 | -1.7 million USD | ? USD |
| 2022Q4 | -2.8 million USD | ? USD |
| 2022Q3 | -5.4 million USD | ? USD |
| 2022Q2 | -3.7 million USD | ? USD |
| 2022Q1 | -7.5 million USD | ? USD |
| 2021Q4 | -7.5 million USD | ? USD |
| 2021Q3 | -7.7 million USD | ? USD |
| 2021Q2 | -8.4 million USD | ? USD |
| 2021Q1 | -8.9 million USD | ? USD |
| 2020Q4 | -10.3 million USD | ? USD |
| 2020Q3 | -6.9 million USD | ? USD |
| 2020Q2 | -5.5 million USD | ? USD |
| 2020Q1 | -6.1 million USD | ? USD |
| 2019Q4 | -8.3 million USD | ? USD |
| 2019Q3 | -4.5 million USD | ? USD |
| 2019Q2 | -4.2 million USD | ? USD |
| 2019Q1 | -3.5 million USD | ? USD |
| 2018Q4 | -3.7 million USD | 538000 USD |
| 2018Q3 | -959000 USD | 1.5 million USD |
| 2018Q2 | -2.7 million USD | 270000 USD |
| 2018Q1 | -2.5 million USD | 268000 USD |
| 2017Q4 | -3.6 million USD | 274000 USD |
| 2017Q3 | -2.8 million USD | 273000 USD |
| 2017Q2 | -2.7 million USD | 270000 USD |
| 2017Q1 | -3.2 million USD | 268000 USD |
| 2016Q4 | -4.8 million USD | 274000 USD |
| 2016Q3 | -3.8 million USD | 193000 USD |
| 2016Q2 | -4.3 million USD | ? USD |
| 2016Q1 | -4.0 million USD | ? USD |
| 2015Q4 | -3.2 million USD | ? USD |
| 2015Q3 | -2.6 million USD | ? USD |
| 2015Q2 | -2.4 million USD | ? USD |
| 2015Q1 | -2.5 million USD | ? USD |
| 2014Q4 | -2.0 million USD | ? USD |
| 2014Q3 | -3.2 million USD | ? USD |
| 2014Q2 | -1.8 million USD | ? USD |
| 2014Q1 | -2.2 million USD | ? USD |
| 2013Q4 | -15.3 million USD | ? USD |
| 2013Q3 | -662000 USD | ? USD |
| 2013Q2 | -953000 USD | ? USD |
| 2013Q1 | -607000 USD | ? USD |
GLMD Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -7.5 million USD | ? USD |
| 2022 | -18.6 million USD | ? USD |
| 2021 | -31.9 million USD | ? USD |
| 2020 | -27.6 million USD | ? USD |
| 2019 | -18.5 million USD | ? USD |
| 2018 | -9.9 million USD | 2.0 million USD |
| 2017 | -12.3 million USD | 1.1 million USD |
| 2016 | -17.0 million USD | 467000 USD |
| 2015 | -10.6 million USD | ? USD |
| 2014 | -9.1 million USD | ? USD |
| 2013 | -17.5 million USD | ? USD |
| 2012 | -3.1 million USD | ? USD |
GLMD
Price: $0.39
52 week price:
Earnings Per Share: -3.02 USD
P/E Ratio: -0.13
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 176487
Ebitda: -2.7 millionMarket Capitalization: 1.3 million